Issue link: https://tmcpulse.uberflip.com/i/1162476
t m c » p u l s e | s e p t e m b e r 2 0 1 9 17 fabricate this device that was for cleaning blood, pulling bacteria out. And it worked." In early 2017, Miller partnered with Alex Wieseler, whom she met while working for a nutra- ceuticals company in Nashville, Tennessee, to start a biomedical device company. PATH EX is part of the current cohort of biomedical device companies at TMCx, the TMC Innovation Institute's accelerator program. Miller's device, which fits in the palm of a hand, can diagnose bacterial infection in the blood by capturing and removing pathogens and their associated toxins. The I wouldn't even say that I'm recovered. I still don't feel normal. It took me two years to get to a point where I could function like a normal person, where I didn't really slur my words and I could go do normal things like go out to dinner and things like that. — SINEAD MILLER CEO of PATH EX and associated toxins and flows the clean blood back into the patient. Creating a medical device and taking it to market is a process not for the faint-hearted. Miller knows it's a journey as arduous as it is rewarding. She's been down a similar road before. Born to ride At the age of 3, Miller could be found on her bike, pedaling around the race track while her father, for- mer superbike racer Rex Miller, was competing. Her mom waited on the sidelines, ready in case her father needed a tune-up. ➟ device takes a five-milliliter blood sample from a patient suspected of having sepsis or a bacterial infec- tion, separates the bacteria from the clean blood and allows doctors to immediately test the bacteria. In addition, PATH EX has developed a therapeutic device to treat infected patients. Similar to a hemodialysis machine, the device circulates the patient's blood continuously, captures the bacteria